1. Dollar holds gains as investors adjust vaccine expectations  Reuters UK
  2. Dollar dips on vaccine doubts, kiwi soars after RBNZ  Investing.com
  3. Dollar rises again as markets adjust to vaccine hope and higher yields  CNBC
  4. Dollar nurses losses on vaccine doubts, kiwi shines post-RBNZ  Reuters
  5. Dollar Down, With Investors Curbing Vaccine Enthusiasm as Questions Remain  Investing.com
  6. View Full coverage on Google News
The dollar held broad gains on Thursday as investors adjusted some of their expectations about a COVID-19 vaccine, which tempered a recent rally in risk assets but kept enough confidence to support the greenback against safe-havens.The dollar held broad gains on Thursday as investors adjusted some of their expectations about a COVID-19 vaccine, which tempered a recent rally in risk assets but kept enough confidence to support the greenback against safe-havens.

Dollar holds gains as investors adjust vaccine expectations | Reuters

The dollar held broad gains on Thursday as investors adjusted some of their expectations about a COVID-19 vaccine, which tempered a recent rally in risk assets but kept enough confidence to support the greenback against safe-havens.The dollar held broad gains on Thursday as investors adjusted some of their expectations about a COVID-19 vaccine, which tempered a recent rally in risk assets but kept enough confidence to support the greenback against safe-havens.

Dollar holds gains as investors adjust vaccine expectations | Article [AMP] | Reuters

403 Forbidden

While the same systemic issues are still a fundamental matter for the near future, growth concerns may gain traction again – particularly in China with Single’s dayWhile the same systemic issues are still a fundamental matter for the near future, growth concerns may gain traction again – particularly in China with Single’s day

Nasdaq Extends Reversal Relative to Dow, Dollar Flounders after Election and Vaccine News

Monday's announcement from the US drug-maker Pfizer and German biotech company BioNtech that their COVID-19 vaccine proved 90% effective in a large scMonday's announcement from the US drug-maker Pfizer and German biotech company BioNtech that their COVID-19 vaccine proved 90% effective in a large sc

Are currency markets shifting to comparative economics?